Literature DB >> 25775651

Generalized Multinucleate Cell Angiohistiocytoma.

Jennifer A E Doane1, Kerri Purdy2, Sylvia Pasternak2.   

Abstract

BACKGROUND: There are less than 100 cases of multinucleate cell angiohistiocytoma (MCA) currently reported in the literature. It occurs as a localized, asymptomatic, benign proliferation of the skin, characterized histologically by irregular multinucleate cells. Due to its novelty, the etiology of the disease and treatment options are still under investigation.
OBJECTIVE: To report a case of confirmed, generalized MCA along with a review of the literature on the histology, immunology, potential etiology, and treatment of MCA. OBSERVATIONS: The patient was a 41-year-old female with asymptomatic violaceous plaques found on the extensor arms, legs, and trunk. Histopathology revealed increased dilated vascularity and cellularity (composed of mononuclear histiocytes and a few angulated multinucleated giant cells) in the dermis.
CONCLUSIONS: Overall, MCA is a poorly understood, distinct dermatologic phenomenon. Here we present a case of generalized MCA to further the understanding of this disease presentation.
© 2014 Canadian Dermatology Association.

Entities:  

Mesh:

Year:  2015        PMID: 25775651     DOI: 10.2310/7750.2014.14129

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  3 in total

1.  Linear and Bilateral Multinucleated Cell Angiohistiocytoma (MCAH).

Authors:  Valeria Coco; Cristina Guerriero; Alessandro Di Stefani; Ilaria Pennacchia; Ketty Peris
Journal:  J Dermatol Case Rep       Date:  2016-12-31

2.  Multinucleate cell angiohistiocytoma: an uncommon cutaneous tumor.

Authors:  Anderson Alves Costa; Glaucia Ferreira Wedy; Walter Belda Junior; Paulo Ricardo Criado
Journal:  An Bras Dermatol       Date:  2020-05-11       Impact factor: 1.896

3.  Cytoplasmic sharing through apical membrane remodeling.

Authors:  Nora G Peterson; Benjamin M Stormo; Kevin P Schoenfelder; Juliet S King; Rayson Rs Lee; Donald T Fox
Journal:  Elife       Date:  2020-10-14       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.